4//SEC Filing
Davis Thomas Andrew 4
Accession 0001457612-18-000101
CIK 0001457612other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 7:25 PM ET
Size
5.4 KB
Accession
0001457612-18-000101
Insider Transaction Report
Form 4
Davis Thomas Andrew
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2018-10-01+500,000→ 500,000 totalExercise: $0.79Exp: 2028-10-01→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]1. The Stock Option shall become exercisable as to 25% of the maximum number of shares on October 1, 2019, and as to an additional 2.0833% of the total number of shares on each monthly anniversary thereafter
Documents
Issuer
GENOCEA BIOSCIENCES, INC.
CIK 0001457612
Entity typeother
Related Parties
1- filerCIK 0001338185
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 7:25 PM ET
- Size
- 5.4 KB